AUSTIN, Oct. 24, 2025 (GLOBE NEWSWIRE) — Dental Bone Grafts and Substitutes Market Size and Growth Analysis:
According to SNS Insider, the global Buy dental bone grafts and substitutes was valued at USD 1.24 billion in 2023 and is expected to reach USD 2.42 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.72% from 2024 to 2032. This steady expansion is driven by increasing demand for dental implants, increasing loss of dichotomous genes. improving patient outcomes.
Get a free Sample Market Report for Bone Grafts and Substitutes:
Dental bone grafts are necessary to rebuild bone structure prior to implant placement or reconstructive surgery. As more patients seek long-lasting, esthetically appealing dental solutions, implant procedures have become a routine part of modern dentistry. Increasing oral health awareness and cosmetic dentistry trends are further fueling global adoption.
In addition, the introduction of bioactive and synthetic materials that mimic natural bone regeneration while reducing the risks of infection has opened new avenues for product innovation. Ethical and safety concerns about animal-derived materials are also encouraging healthcare providers to turn to synthetic alternatives, particularly in developed markets.
Major Players in the Dental Bone Grafts and Substitutes Market
- Dentsply Sirona Inc.
- Envista Holdings Corporation
- Johnson & Johnson
- Stryker Corporation
- Medtronic Plc
- Institut Straumann AG
- ZimVie Inc.
- Henry Schein Inc.
- RTI Surgical Holdings Inc.
- LifeNet Health
- Dentium Co., Ltd.
- Geistlich Pharma AG
- Integra LifeSciences Holdings Corporation
- Tissue Regenix Group
- Kuraray Co. Ltd.
- BEGO GmbH & Co. KG
- Young Innovations.
- Keystone Dental
- Novabone LLC
- Biotiss Biomaterials LLC
- Collagen Matrix Inc.
- Osteogenic Biomedicine
- Hannox International Corp.
- Meyer Haake GmbH
- Arora Biosurgery Ltd.
Segment Insights
By material type
In 2023, xenografts segment accounted for the largest revenue share of 49.3% as they are widely used due to their high availability, biocompatibility, and cost-effectiveness compared to autografts and allografts. Synthetic bone graft is likely to grow faster due to the growing trends of synthetic grafts, the increasing demand is mainly attributed to the advancement in biomaterials such as hydroxyapatite and bioactive glass.
By Request
Socket preservation dominated the application segment in 2023 with a market share of 37.3% due to the number of tooth extractions increasing and patients opting for dental implants, which require bone volume for proper placement. The sinus lift segment is likely to grow faster due to increasing cases of atrophic maxilla and increasing demand for dental implants, especially among the aging population.
With end use
The largest market share was recorded for the dental clinic segment in 2023, accounting for 80.3% of the total revenue due to the increasing number of independent dentists offering bone grafting procedures among others. The hospital segment is expected to show the highest growth rate due to expanding complex dental procedures requiring multi-specialty care, addition of improved hospital infrastructure with highly advanced surgical facilities and cases of severe bone defects.
By Region
In 2023, North America held the largest share of the global dental bone grafts and substitutes market, with a revenue share of 38.23%. Growth is driven by well-developed healthcare infrastructure, widespread adoption of dental implants, and a growing elderly population that is vulnerable to bone loss and periodontal disease.
Asia Pacific The region is expected to have the highest growth rate due to increased incidence of dental diseases, improved disposable income, and increased awareness regarding dental aesthetics.
Need any customizing research on Dental Bone Grafts and Substitutes Market, Inquire Now:
Recent news:
- In January 2025, NovaBone Products has partnered with BEGO to distribute its advanced Dental Putty with MIS Dispenser in Europe, marking a major development in the dental bone graft market. This collaboration will enhance access to innovative bioactive synthetic bone graft solutions for professionals at the IDS 2025 event.
- In March 2024, The US Food and Drug Administration (FDA) has published draft guidance for sponsors of dental bone graft devices advising the use of animal studies to meet specific control requirements. This guidance is intended to supplement and in some cases replace previous relevant guidance.
Exclusive sections of the Exhibition (The USPs):
- BONE DEFICIENCY BURDEN MAP – helps you understand the incidence and prevalence of bone defects across regions in 2023 to identify high-need patient groups and pockets of demand based on the procedure.
- COMPARISON OF PRESCRIPTIONS & ADOPTION OF STANDARDS – helps you compare regional differences in clinician preferences between autografts, allografts, xenografts and synthetic surrogates to discover where surrogacy opportunities are taking place.
- RETURN INDEX & ACCESS COST – helps you assess how insurance coverage, health care spending, and reimbursement variation in 2023 enable or constrain the adoption of high-quality vaccine materials and adjuncts.
- PIPELINE INNOVATION & TECHNOLOGY TRACKER – helps you uncover commercialization opportunities by evaluating the potential of emerging biomaterials such as bioactive ceramics, growth factor-enriched matrices, and 3D-printed scaffolds.
- CLINICAL PRACTICE SHIFT DETAILS – helps you identify the evolution from invasive transplantation to minimally invasive regenerative approaches, guided bone regeneration and chairside biologics shaping future adoption.
- COMPETITIVE LANDSCAPE & REPLACEMENT PRESSURE – helps you gauge the position of leading manufacturers, their technology bets, local footprint and how innovation pipelines are changing competitive intensity and procurement decisions.
Buy the Dental Bone Grafts and Substitutes Market Report Now:
Dental Bone Grafts and Substitutes Market Reference Field
| Properties Reference | Details |
| Market size in 2023 | $1.24 billion |
| Market size by 2032 | $2.42 billion |
| CAGR | CAGR of 7.72% From 2024 to 2032 |
| Base year | 2023 |
| Prognostic period | 2024-2032 |
| Historical Evidence | 2020-2022 |
| Basic Departments | By material type [Autograft, Allograft (Demineralized Bone Matrix, Others), Xenograft, Synthetic]
By Request [Ridge Augmentation, Sinus Lift, Periodontal Defect Regeneration, Implant Bone Regeneration, Socket Preservation] With end use [Hospitals, Dental Clinics] |
| Regional Analysis/Coverage | North America (USA, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East and Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East, Mexico, Colraz, Mexico, Lat. Latin America). |
Access Full Report Details for Dental Bone Grafts and Substitutes Market Analysis and Outlook:
[For more information or need any customization research mail us at info@snsinsider.com]
About us:
SNS Insider is one of the leading market research and consulting firms dominating the market research industry worldwide. Our company’s goal is to provide customers with the knowledge they need to operate in changing conditions. In order to provide you with current, accurate market data, consumer information and opinions so you can make informed decisions, we use a variety of techniques including surveys, video chats and focus groups around the world.
